Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
11/2009
11/24/2009CA2385882C Tyrosine derivatives
11/19/2009WO2009105746A3 Triazoles and processes for producing the same
11/19/2009US20090286989 Process for High Purity Anastrozole
11/19/2009US20090286976 One-pot synthesis of fluorinated ionic liquids
11/19/2009US20090286835 Novel compounds
11/19/2009US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/18/2009EP2018367B1 Novel microbiocides
11/18/2009EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors
11/18/2009CN101583605A Triazole derivative as an HSP 90 inhibitor
11/18/2009CN101580700A Chemical mechanical polishing composition
11/18/2009CN100560573C Process for preparing high purity letrozole
11/17/2009US7618971 Mitotic kinesin inhibitors
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/12/2009WO2009137651A2 Fungicidal substituted azoles
11/12/2009WO2009137538A2 Fungicidal substituted azoles
11/11/2009EP2114904A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
11/11/2009EP1742908B1 Non-nucleoside reverse transcriptase inhibitors
11/11/2009CN101575320A Water-soluble triazole antifungal compound
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615514 Pre-emergence and post-emergence selective herbicidal compositions comprising an active compound combination consisting of substituted arylsulphonylaminocarbonyl-triazolinones and/or salts thereof and at least one compound which improves crop plant compatibility
11/05/2009US20090275619 Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
11/05/2009US20090275598 Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/04/2009EP1727804B1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
11/04/2009CN101573344A Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612064 Sulfopyrroles
10/2009
10/29/2009WO2009131654A2 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009US20090270633 Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-triazol-1-yl)methyl] benzonitrile and 4-[1-(1H-1,2,4-triazol-1-yl)methylene benzonitrile intermediate
10/29/2009US20090270632 2-(2-hydroxy-5-methylphenyl) benzotriazole, triethylamine in presence of N,N-dimethylaniline solvent to make a solution, adding 3-chloro-2-alkyl propylene, exchanging air in the reaction vessel for N2, heating to allow a Claisen rearrangement to form 1-methallyl-2-(2-hydroxy-5-methylphenyl) benzotriazole
10/29/2009US20090270471 Method for inhibiting mycotoxin production
10/29/2009US20090270431 Cyclopentenol Nucleoside Compounds Intermediates for their Synthesis and Methods of Treating Viral Infections
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/28/2009CN101568526A Process for purification of anastrozole
10/28/2009CN101565406A Preparation process for cyproconazole
10/27/2009US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2437006C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009WO2009128919A1 Deuterium bearing analogs of anastrozole as aromatase inhibitors for the treatment of breast cancer
10/22/2009WO2009078036A3 Process and intermediate of letrozole
10/22/2009US20090264657 Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090263438 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
10/21/2009CN101560187A Binary eutectic ionic liquid and preparation method thereof
10/15/2009WO2009075778A3 Nonpeptidic inhibitors of cruzain
10/15/2009US20090258999 Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
10/15/2009US20090258884 Substituted amides
10/14/2009EP2108013A2 Crystalline forms of deferasirox
10/14/2009CN101558050A Non-nucleoside reverse transcriptase inhibitors
10/14/2009CN101558049A Substituted pyrazole and triazole compounds as KSP inhibitors
10/14/2009CN100549014C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
10/14/2009CN100549003C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/13/2009US7601859 Organometallic complexes
10/08/2009WO2009123569A1 Method for treating neurological disorders with imidazolium and imidazolinium compounds
10/08/2009US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content
10/08/2009US20090253756 Indole Amide Derivatives as EP4 Receptor Antagonists
10/08/2009US20090253740 Substituted n-bicyclicalkyl bicycliccarboxyamide compounds
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598280 For the treatment, prevention and management of inflammatory and autoimmune diseases and disorders; for example, (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol
10/06/2009US7598279 Neurotherapeutic azole compounds
10/06/2009US7598245 Pyruvate dehydrogenase kinase, c-KIT, cyclin-dependent kinases, Janus kinases, FLT3 kinase, AUR-2 kinase, tyrosine kinase; 1-(2-amino-4-pyridyl)-3-phenylaminotriazoles; combination therapy with antiallergens, immunomodulators, antiproliferative agents; Alzheimer's, Parkinson's, Multiple Sclerosis, asthma
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009075890A8 Method for synthesis of triazole compounds that modulate hsp90 activity
10/01/2009WO2008147763A8 Mmp inhibitors and methods of use thereof
10/01/2009US20090247765 Process for preparing pure anastrozole
10/01/2009CA2719243A1 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
09/2009
09/30/2009CN101544612A Method for synthesizing 1-substituted-1,2,3-triazole by calcium carbide
09/30/2009CN101544611A Substituted 1,2,4-triazole complex and application thereof as nonlinear optical and ferroelectric material
09/30/2009CN101544606A Malononitrile compound and use thereof
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/29/2009CA2449800C Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
09/29/2009CA2439310C Process for preparing fluconazole and its crystal modifications
09/29/2009CA2379026C Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
09/24/2009WO2009115547A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
09/24/2009WO2009115503A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof
09/24/2009WO2009115486A1 Triazole amide derivatives for use in therapy
09/24/2009WO2007068822A8 Sulphonyl-1,2,4-triazole salts
09/24/2009WO2007068822A3 Sulphonyl-1,2,4-triazole salts
09/24/2009US20090239877 Novel 1,2,4-triazole derivatives and process of manufacturing thereof
09/24/2009US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
09/24/2009US20090239760 Method for the Identification of New Leads for Drug Candidates
09/24/2009CA2718744A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof
09/24/2009CA2714662A1 Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators
09/23/2009EP2103602A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof
09/23/2009EP2102175A1 Triazole derivative as an hsp 90 inhibitor
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 178